More Accessible COVID-19 Technology on the Horizon: The National Institute of Health Licenses its COVID-19 Tech Patents to the WHO and the Medicines Patent Pool Posted on 10 June 2022 More Accessible COVID-19 Technology on the Horizon: The National Institute of Health Licenses its COVID-19 Tech Patents to the WHO and the Medicines Patent Pool Posted on 10 June 2022
How IP Waivers Can Help Manage the Omicron Strain Posted on 17 February 2022 How IP Waivers Can Help Manage the Omicron Strain Posted on 17 February 2022
Phone, Wallet, Keys…Vaccine Passport? Canada’s Response to the Vaccine Passport Debate Posted on 17 August 2021 Phone, Wallet, Keys…Vaccine Passport? Canada’s Response to the Vaccine Passport Debate Posted on 17 August 2021
Biden Support for Covid-19 Intellectual Property Waiver: A Step Below Progress? Posted on 12 May 2021 Biden Support for Covid-19 Intellectual Property Waiver: A Step Below Progress? Posted on 12 May 2021
Are Intellectual Property Rights Hindering the COVID-19 Vaccine Manufacturing Potential? Posted on 6 May 2021 Are Intellectual Property Rights Hindering the COVID-19 Vaccine Manufacturing Potential? Posted on 6 May 2021
Compulsory Licensing: A Potential Tool to Increase Vaccine Supply in Canada? Posted on 9 April 2021 Compulsory Licensing: A Potential Tool to Increase Vaccine Supply in Canada? Posted on 9 April 2021
TRIPS: A Barrier to Covid-19 Vaccine Access? Posted on 26 March 2021 TRIPS: A Barrier to Covid-19 Vaccine Access? Posted on 26 March 2021
War or Co-operation: Implications of COVID-19 Vaccine Patents Posted on 12 January 2021 War or Co-operation: Implications of COVID-19 Vaccine Patents Posted on 12 January 2021
IP Regimes May Delay a Timely Delivery of New COVID-19 Vaccines Posted on 5 January 2021 IP Regimes May Delay a Timely Delivery of New COVID-19 Vaccines Posted on 5 January 2021
